Latest News

  • Flatiron Health And Foundation Medicine Partner To Launch Clinico-Genomic Database

    Diagnostics World News Brief | Flatiron Health and Foundation Medicine today announced the launch of a clinico-genomic database designed to help researchers and biopharmaceutical partners accelerate the development of targeted therapeutics and immunotherapies to treat cancer.

    Nov 3, 2016

  • Good Start Genetics Brings First NGS Test to Amazon

    Diagnostic World News Brief | Good Start Genetics announced it has launched its VeriYou genetic test for couples on Amazon. Amazon’s marketplace, paired with Good Start’s proprietary and low-cost NGS platform, will reduce barriers to enable access to millions of couples starting a family.

    Nov 2, 2016

  • Illumina Launches TruSight RNA Fusion

    Diagnostics World News Brief | Illumina has created the TruSight RNA Fusion Panel, a comprehensive cancer panel which enables analysis of limited and degraded samples. The panel provides in-depth assessment of 500+ genes associated with fusions in cancer.

    Nov 1, 2016

  • IBM Watson Quest Diagnostics Partner in Cancer Precision Medicine Push

    Fortune | IBM Watson and Quest Diagnostics have struck a partnership that could extend precision medicine services to thousands of cancer patients. Under the new service, doctors would send Quest a patient's tissue sample so that it can be genetically sequenced.

    Oct 31, 2016

  • Genetic Testing Fumbles Revealing Dark Side of Precision Medicine

    STAT | Problems with the databases used to interpret patients' genetic profiles can lead to inappropriate treatment with devastating consequences, researchers say.

    Oct 31, 2016

  • MDxHealth Aquires CPT Code from the AMA

    Diagnostics World Brief | MDxHealth has been granted a Category I MAAA CPT code by the American Medical Association. The unique ConfirmMDx CPT code, effective in January 2018, will streamline reimbursement from US government programs such as Medicare and Medicaid, as well as commercial health insurance companies.

    Oct 31, 2016

  • News and Notes in Diagnostics October 2016

    Diagnostics World News Briefs | News from Cirina, Illumina, HudsonAlpha, and more.

    Oct 28, 2016

  • NGS-Based Diagnostics Out of the Dark Ages with GATK

    Diagnostics World News | GATK is allowing researchers to take the next step in NGS-based diagnostics. A reputation for accuracy has helped GATK achieve huge gains in user base and ubiquity as a platform. Andrew Dauber from the Cincinnati Center for Growth Disorders shares his thoughts on the subject.

    Oct 25, 2016

  • Cleveland Clinic Joins Mass General In Study To Diagnose Pediatric Pneumonia With Smartphone

    MobiHealthNews | ResApp, an Australian company developing an app to diagnose respiratory conditions based on cough sounds, has secured the first of three IRB approvals for its upcoming Smartcough-C pediatric trial, which will take place at the Cleveland Clinic, Massachusetts General Hospital, and a third site yet to be announced.

    Oct 24, 2016

  • What IBMs Genomic Partnership With Quest Says About Thermo Fisher Diagnostics Peers

    TheStreet | The collaboration between IBM and Quest "is certainly interesting for the clinical sequencing market," wrote Evercore ISI analyst Ross Muken in a Tuesday note, pointing to the goal of bringing next-generation sequencing (NGS) to community oncologists.

    Oct 19, 2016

  • Surprisingly Few New Parents Enlist in Study to Have Baby’s Genome Sequenced

    Science | When parents were offered option of having their newborn's genes probed to guide medical decisions via the BabySeq project, most declined. Only 7% of parents have agreed to participate.

    Oct 19, 2016

  • Gene Therapy In U.S. Is On Track For Approval Next Year

    MIT Technology Review | Spark Therapeutics is within striking distance of a landmark green light from the FDA for its treatment for certain forms of blindness.

    Oct 18, 2016

  • Illumina, Genentech, BIO Weigh in on FDA Draft Guidance on Companion Diagnostics

    RAPS | The draft guidance, released by FDA in July, is meant to be a practical guide to assist drug and in vitro diagnostic sponsors in developing the two products simultaneously.

    Oct 18, 2016

  • Episona Launches Male Infertility Test

    Diagnostics World Brief | Episona today announced the launch of its male fertility test, Seed. Seed evaluates epigenetic changes to DNA to predict the risk for male factor infertility and poor embryo development.

    Oct 17, 2016

  • White House To Announce Big Push For Cancer Blood Tests

    Forbes | The White House, as part of the Cancer Moonshot effort being run by Vice President Joe Biden, is announcing a major push to develop blood tests that can detect and monitor cancer, that aims to unite makers of diagnostic tests, drugs, and other cancer-related products.

    Oct 17, 2016

  • FDA Public Workshop Sheds Light On NGS Test Guidances

    Diagnostics World | On Friday, September 23, 2016, the FDA convened a public workshop on Adapting Regulatory Oversight of NGS-Based Tests, for discussion and comment on its recently released draft guidances for next generation sequencing based in-vitro diagnostic tests.

    Oct 13, 2016

  • Good Start Genetics Offers Two Disorder Test

    Diagnostics World Brief  Today, Good Start Genetics launched VeriYou, its saliva-based screening test for two of the most common inherited genetic disorders: cystic fibrosis (CF) and spinal muscular atrophy (SMA). The two-disorder test will be offered through physicians, and will serve as a complement to the multi-disorder testing the company offers.

    Oct 13, 2016